drug-resistant epilepsy
Metabolic · 2012–2021
2decisions
2medicines
0carried consumer input
0individual submissions
No submission for this condition has carried consumer input, including the one made since the comments facility came into use.
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate Ketogenic diet for infants and children with drug-resistant epilepsy or other conditions requiring ketogenic dietary management. | Mar 2021 | Recommended with restriction | none received |
| lacosamide Add-on therapy, in combination with two or more anti-epileptic drugs for the treatment of partial onset seizures and secondarily generalised seizures, in a… | Nov 2012 | Recommended with restriction | no section in document |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 0 of 1 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.